BUSINESS
Pfizer, Mylan Ink Strategic Collaboration in Japan Generics Biz; Aim for No. 3 in Market
Pfizer Inc. and Mylan Inc. said on August 22 that they have signed an exclusive long-term strategic collaboration in the generic drug business in Japan. Under the deal, Pfizer Japan will be primarily responsible for the sales and marketing of…
To read the full story
Related Article
- In Japan Too, Pfizer and Mylan Prepping for Pending Viatris Integration
February 12, 2020
- Mylan Japan Offers Severance Package for 110 Sales Reps
March 29, 2016
BUSINESS
- Lunsumio Combo Hits PIII Goal in Follicular Lymphoma: Roche
September 18, 2026
- Padcev-Keytruda Gets CHMP Nod for Expanded MIBC Use
September 18, 2026
- SanBio Eyes October Start for Akuugo Treatment
September 18, 2026
- Toho Unit to Launch Pharma-Wholesaler Payment Service
September 18, 2026
- Astellas Names Marino General Counsel, Compliance Chief
September 18, 2026
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…





